English language
Child and Adolescent Mental Health Rajanagarindra Institute is the government organization supported by the Department of Mental Health under the Ministry of Public Health. It was established as the Institute of Child and Adolescent Mental Health on August 29, 2001. In 2003
Academic : Adolescence Depression
beyondblue: the national depression initiative is an independent, not-for-profit organisation. Since beyondblue’s establishment in October 2000, it has been the policy of the beyondblue Board not to accept funding from or partner with pharmaceutical companies. None of beyondblue’s activities is funded by pharmaceutical companies. This allows beyondblue to retain independence and impartiality and promote evidence-based approaches to depression, anxiety and related disorders across all program areas. Disclosure of interests All those invited to become a member of the Expert Working Committee that developed these Guidelines were asked to complete a ‘Certification of Disclosure of Interest’ form, which advised that there were no conflicts of interest, prior to their being accepted onto the Expert Working Committee. Throughout t
31 Mar 2016 13:46
Abstract Adolescent depression is a prevalent and disabling condition resultingin emotional suffering and social and educational dysfunction.Care for adolescent depression is suboptimal and could be improvedthrough the development and use of quality indicators (QIs). Thisarticle reports on the development of a care pathway and QIs forthe primary and specialty care management of adolescent depression from case identification through symptom remission. It presents evidencefrom a review of adolescent clinical practice guidelines andresearch literature to support QIs at critical nodes in the pathway,and describes implications for practice based on existing evidence.Barriers to measure development are identified, including gaps inempirical evidence, and a research agenda is suggested. Pediatrics2013;132:e996–e1009
31 Mar 2016 13:45
ABSTRACT This practice parameter describes the epidemiology, clinical picture, differential diagnosis, course, risk factors, and pharmacological and psychotherapy treatments of children and adolescents with major depressive or dysthymic disorders. Side effects of the antidepressants, particularly the risk of suicidal ideation and behaviors are discussed. Recommendations regarding the assessment and the acute, continuation, and maintenance treatment of these disorders are based on the existent scientific evidence as well as the current clinical practice. J. Am. Acad. Child Adolesc. Psychiatry, 2007; 46(11):1503Y1526. Key Words: major depressive disorder, dysthymic disorder, evaluation, treatment, antidepressants, selective serotonin reuptake inhibitors, psychotherapy, practice parameter.
31 Mar 2016 13:42